Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Podrobná bibliografie
Hlavní autoři:	Ziberna, K, Recalde, A, Carnicer, R, Casadei, B
Médium:	Conference item
Vydáno:	Springer Berlin Heidelberg 2016

Podobné jednotky

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
Autor: Mighiu, AS, a další
Vydáno: (2021)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
Autor: Ziberna, K
Vydáno: (2020)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
Autor: Mighiu, A, a další
Vydáno: (2017)

Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
Autor: Simon, J, a další
Vydáno: (2016)

BH4 supplementation as a new treatment for diabetic cardiomyopathy
Autor: Carnicer, R, a další
Vydáno: (2019)

Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK Biobank
Autor: Oster, J, a další
Vydáno: (2020)

Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model
Autor: Wei-Chieh Lee, a další
Vydáno: (2024-11-01)

Reduced nitric oxide bioactivity increases platelet activation in mice with streptozotocin-induced diabetes mellitus
Autor: Schafer, A, a další
Vydáno: (2003)

Mechanisms of atrial fibrillation
Autor: Wijesurendra, RS, a další
Vydáno: (2019)

Catheter ablation of atrial fibrillation in patients with diabetes mellitus
Autor: Allen Wang, MD, a další
Vydáno: (2020-08-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
Autor: T. M. Boychuk, a další
Vydáno: (2017-09-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
Autor: T. M. Boychuk, a další
Vydáno: (2017-09-01)

BH4 increases nNOS Activity and preserves left ventricular function in diabetes
Autor: Carnicer Hijazo, R, a další
Vydáno: (2021)

Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus
Autor: Ling-ling Qian, a další
Vydáno: (2023-01-01)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
Autor: Andreas S. Papazoglou, a další
Vydáno: (2021-02-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice
Autor: Narumi Takahashi, a další
Vydáno: (2024-01-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice.
Autor: Narumi Takahashi, a další
Vydáno: (2024-01-01)

Streptozotocin-induced diabetes mellitus affects lysosomal enzymes in rat liver
Autor: G.B. Peres, a další
Vydáno: (2014-06-01)

Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man
Autor: Reilly, S, a další
Vydáno: (2015)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
Autor: R. Gimenes, a další
Vydáno: (2018-01-01)

Streptozotocin model of stable diabetes mellitus
Autor: G. N. Skaletskaya, a další
Vydáno: (2019-01-01)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
Autor: Loryn J. Bohne, a další
Vydáno: (2019-02-01)

How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus
Autor: Naoya Kataoka, a další
Vydáno: (2024-02-01)

ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN
Autor: Alexey D. Ehrlich
Vydáno: (2018-12-01)

Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
Autor: Yubi Lin, a další
Vydáno: (2013-01-01)

The incidence of atrial fibrillation in type 2 diabetes mellitus patients
Autor: Jandrić-Kočič Marijana
Vydáno: (2020-01-01)

Morphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitus
Autor: Oksana Anatolyevna Pivovarova, a další
Vydáno: (2013-12-01)

Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
Autor: Yuqing Li, a další
Vydáno: (2012-04-01)

Seek and ye shall find… subclinical atrial fibrillation in high-risk elderly patients.
Autor: Wijesurendra, R, a další
Vydáno: (2017)

Evaluation of plasma homocysteine status in streptozotocin induced-diabetes mellitus in rabbit
Autor: K Azimzadeh, a další
Vydáno: (2009-08-01)

Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death
Autor: Edwin A. Homan, a další
Vydáno: (2019-01-01)

Diabetes Mellitus Is an Independent Risk Factor for a Stiff Left Atrial Physiology After Catheter Ablation for Atrial Fibrillation
Autor: Moon-Hyun Kim, a další
Vydáno: (2022-03-01)

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
Autor: JungMin Choi, a další
Vydáno: (2023-01-01)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
Autor: Andrey Alexeevich Aleksandrov, a další
Vydáno: (2011-03-01)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
Autor: Alexander Kogan, a další
Vydáno: (2023-03-01)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
Autor: Hisao Ogawa, a další
Vydáno: (2022-03-01)

OSC16: Effects of streptozotocin-induced diabetes mellitus on peri-implantitis
Autor: ..
Vydáno: (2018-01-01)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
Autor: Reilly, S, a další
Vydáno: (2009)

Atrial appendage closure is associated with increased risk for postoperative atrial fibrillation
Autor: Jeffrey H. Shuhaiber, a další
Vydáno: (2024-11-01)

Is increased myocardial oxidative stress an early event in the natural history of atrial fibrillation?
Autor: Reilly, S, a další
Vydáno: (2007)